GC-MS and LC-(high-resolution)-MS n studies on the metabolic fate and detectability of camfetamine in rat urine

Analytical and Bioanalytical Chemistry

Volumn 406, Issue 16, 2014, Pages 3815-3829

  Welter, Jessica ^a   Kavanagh, Pierce ^b   Maurer, Hans H ^a  

^a SAARLAND UNIVERSITY   (Germany)

^b ST JAMES S HOSPITAL   (Ireland)

Author keywords

Camfetamine; Cytochrome P450; Designer drugs; GC MS; Metabolism

Indexed keywords

ACETYLATION; ALKYLATION; AROMATIC COMPOUNDS; BODY FLUIDS; CATALYSIS; DRUG INTERACTIONS; GAS CHROMATOGRAPHY; HYDROXYLATION; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; METABOLISM; METABOLITES; PHYSIOLOGY; RATS;

CAMFETAMINE; CYTOCHROME-P450; DESIGNER DRUGS; GC-MS;

BIOMOLECULES;

RATTUS;

ANOREXIGENIC AGENT; CYTOCHROME P450; FENCAMFAMIN; NORBORNANE DERIVATIVE;

ANIMAL; CHEMICAL STRUCTURE; CHEMISTRY; HUMAN; LIQUID CHROMATOGRAPHY; MALE; MASS FRAGMENTOGRAPHY; MASS SPECTROMETRY; METABOLISM; RAT; URINE; WISTAR RAT;

ANIMALS; APPETITE DEPRESSANTS; CHROMATOGRAPHY, LIQUID; CYTOCHROME P-450 ENZYME SYSTEM; GAS CHROMATOGRAPHY-MASS SPECTROMETRY; HUMANS; MALE; MASS SPECTROMETRY; MOLECULAR STRUCTURE; NORBORNANES; RATS; RATS, WISTAR;

EID: 84903785412     PISSN: 16182642     EISSN: 16182650     Source Type: Journal    
DOI: 10.1007/s00216-014-7796-6     Document Type: Article

References (26)

1. DeLucia R, Bernardi MM, Scavone C, Aizenstein ML (1984) On the mechanism of central stimulation action of fencamfamine. Gen Pharmacol 15:407-410
2. DeLucia R, Planeta CS, Scavone C, Aizenstein ML (1987) Reduction of food intake by fencamfamine in rats. Gen Pharmacol 18:21-23
3. Planeta CS, Scavone C, De LR, Aizenstein ML (1987) Behavioural effects of long-term administration of fencamfamine: neurochemical implications. Gen Pharmacol 18:347-349
4. Planeta CS, Aizenstein ML, Scavone C, DeLucia R (1989) Behavioral and neurochemical effects of fencamfamine on rats: a chronobiologic approach. Chronobiol Int 6:313-320
5. Planeta CS, Aizenstein ML, DeLucia R (1995) Reinforcing properties of fencamfamine: involvement of dopamine and opioid receptors. Pharmacol Biochem Behav 50:35-40
6. Kuczenski R, Segal DS, Aizenstein ML (1991) Amphetamine, cocaine, and fencamfamine: relationship between locomotor and stereotypy response profiles and caudate and accumbens dopamine dynamics. J Neurosci 11:2703-2712
7. Delbeke FT, Debackere M (1992) Disposition of human drug preparations in the horse. II. Orally administered fencamfamine. J Pharm Biomed Anal 10:651-656
8. Delbeke FT, Debackere M (1981) Detection and metabolism of fencamfamine and the influence of acetazolamide on its urinary excretion. Biopharm Drug Dispos 2:17-30
9. Kavanagh P, Angelov D, O'Brien J, Power JD, McDermott SD, Talbot B, Fox J, O'Donnell C, Christie R (2013) The synthesis and characterization N-methyl-3-phenyl-norbornan-2-amine (Camfetamine). Drug Test Anal 5:247-253
10. Maurer HH, Pfleger K, Weber AA (2011) Mass Spectral Library of Drugs, Poisons, Pesticides, Pollutants and their Metabolites. Wiley-VCH, Weinheim
11. Welter J, Meyer MR, Wolf E, Weinmann W, Kavanagh P, Maurer HH (2013) 2-Methiopropamine, a thiophene analogue of methamphetamine: studies on its metabolism and detectability in the rat and human using GC-MS and LC-(HR)-MS techniques. Anal Bioanal Chem 405:3125-3135
12. n. Anal Bioanal Chem 406:1957-1974
13. Meyer GMJ, Meyer MR, Wissenbach DK, Maurer HH (2013) Studies on the metabolism and toxicological detection of glaucine, an isoquinoline alkaloid from Glaucium flavum (Papaveraceae), in rat urine using GC-MS, LC-MSn and LC-high-resolution MSn. J Mass Spectrom 48:24-41
14. Meyer MR, Schmitt S, Maurer HH (2013) Studies on the metabolism and detectability of the emerging drug of abuse diphenyl-2-pyrrolidinemethanol (D2PM) in rat urine using GC-MS and LC-HR-MS/MS. J Mass Spectrom 48:243-249
15. n urine drug screening procedure - exemplified for antidepressants. Anal Bioanal Chem 400:79-88
16. n) screening concept. Anal Bioanal Chem 400:3481-3489
17. Maurer HH, Pfleger K, Weber AA (2011) Mass Spectral and GC Data of Drugs, Poisons, Pesticides, Pollutants, and their Metabolites. Wiley-VCH, Weinheim
18. Ewald AH, Ehlers D, Maurer HH (2008) Metabolism and toxicological detection of the designer drug 4-chloro-2,5-dimethoxyamphetamine in rat urine using gas chromatography-mass spectrometry. Anal Bioanal Chem 390:1837-1842
19. Meyer MR, Peters FT, Maurer HH (2010) Automated mass spectral deconvolution and identification system for GC-MS screening for drugs, poisons, and metabolites in urine. Clin Chem 56:575-584
20. Meyer MR, Wilhelm J, Peters FT, Maurer HH (2010) Beta-keto amphetamines: studies on the metabolism of the designer drug mephedrone and toxicological detection of mephedrone, butylone, and methylone in urine using gas chromatography-mass spectrometry. Anal Bioanal Chem 397:1225-1233
21. McLafferty FW, Turecek F (1993) Interpretation of Mass Spectra. University Science Books, Mill Valley
22. Smith RM, Busch KL (1999) Understanding Mass Spectra - A Basic Approach. Wiley, New York
23. de-Zeeuw RA, Franke JP, Maurer HH, Pfleger K (1992) Gas Chromatographic Retention Indices of Toxicologically Relevant Substances and their Metabolites (Report of the DFG commission for clinical toxicological analysis, special issue of the TIAFT bulletin). VCH Publishers, Weinheim
24. Kovats E (1958) Gaschromatographische Charakterisierung organischer Verbindungen. Teil 1. Retentionsindices aliphatischer Halogenide, Alkohole, Aldehyde, und Ketone. Helv Chim Acta 41:1915-1932
25. n. Anal Bioanal Chem 405:6307-6321
26. Sharma V, McNeill JH (2009) To scale or not to scale: the principles of dose extrapolation. Br J Pharmacol 157:907-921